CAMBRIDGE, Mass.--(BUSINESS WIRE)--
Ironwood
Pharmaceuticals, Inc. (NASDAQ: IRWD) will present at the Credit
Suisse 2010 Healthcare Conference on Thursday, November 11, 2010 at
11:30 a.m. Mountain Time / 1:30 p.m. Eastern Time at the Arizona
Biltmore in Phoenix.
A live webcast of Ironwood's presentation will be accessible through the
Investors section of the company's website at www.ironwoodpharma.com.
To access the webcast, please log on to the Ironwood website
approximately 15 minutes prior to the start of the presentation to
ensure adequate time for any software downloads that may be required. A
replay of the webcast will be available on Ironwood's website for 14
days following the conference.
About Ironwood Pharmaceuticals
Ironwood Pharmaceuticals (NASDAQ: IRWD) is an entrepreneurial
pharmaceutical company dedicated to the art and science of great
drugmaking. Linaclotide, Ironwood's GC-C agonist, is being evaluated in
a confirmatory Phase 3 program for the treatment of irritable bowel
syndrome with constipation (IBS-C) and chronic constipation. Ironwood
also has a growing pipeline of additional drug candidates in earlier
stages of development. Ironwood is located in Cambridge, Mass. To learn
more, visit www.ironwoodpharma.com.
Ironwood Pharmaceuticals, Inc.
Susan Brady, 617-621-8304
Corporate
Communications
[email protected]
Source: Ironwood Pharmaceuticals, Inc.
News Provided by Acquire Media